Technology | Ultrasound Imaging | October 17, 2018

Nanosonics Trophon2 High Level Disinfection System Available in U.S. and Canada

New device reduces risk of ultrasound probe cross-infection and is safe for environment

Nanosonics Trophon2 High Level Disinfection System Available in U.S. and Canada

October 17, 2018 — Nanosonics announced the commercial availability of its Trophon2 high level disinfection (HLD) system for ultrasound probe decontamination in the United States and Canada. The new device, which prevents exposure to hazardous chemicals, offers medical professionals a smart solution that helps ensure compliance with the latest guidelines for reprocessing of surface and endocavity ultrasound probes. The system is also equipped with an automatic traceability solution that creates audit-ready digital records of each HLD cycle with the option for information technology (IT) integration.

Initial feedback from customers in North America implementing Trophon2 as standard-of-care for HLD probe reprocessing has been positive, according to Nanosonics. The company showcased the new device and its suite of HLD products at the 2018 Society of Diagnostic Medical Sonography (SDMS) annual conference, Oct. 4-7 in Orlando, Fla.

Ultrasound imaging is one of the fastest growing medical procedures due in part to its expanded use across multiple medical specialties.1 While ultrasound is safe, there are risks of cross-contamination if probe reprocessing is not performed correctly. Global guidelines now recommend HLD between patients for ultrasound probes used in semi-critical procedures, including intracavity procedures, and for surface ultrasound procedures on non-intact or broken skin, to effectively reduce the risk of infection for patients and staff.

Yet, adhering to HLD best practices is not routinely implemented on several ultrasound procedures that require it. This was recently highlighted by a survey published in the American Journal of Infection Control, showing that there are a large number of procedures where HLD is not being performed between patients. Improper infection prevention practice associated with ultrasound probe use has been linked to increased infection risk, outbreaks and death.2

According to Raleigh White, CRA, RT(R), MA, director of imaging services at Hutchinson Regional Medical Center in Kansas, “Since implementing trophon technology as our infection prevention standard of care for ultrasound probe reprocessing, we are significantly more effective at high-level disinfection throughout our facility. Even though ultrasound is one of the safest and most widely-used imaging modalities today, following best practices and eliminating the risk of infection transmission between patients was often time-consuming and required the use of toxic chemicals as well as the need for a special ventilation system within our facility.

“With trophon HLD, the transducer decontamination process is quick, simple and doesn’t require hazardous chemicals,” continued White. “Equally as important, the confidence amongst our sonographers in their ability to eliminate the risks of infection transmission has been raised exponentially since adopting trophon. During my career, I’ve had several Joint Commission surveyors observe the trophon HLD process and I have been told repeatedly that it is the gold standard for maintaining patient and user safety.”

The automated Trophon2 generates a sonically activated, supercharged hydrogen peroxide (H2O2) mist that kills drug-resistant bacteria, fungi and viruses. The device is validated for use with over 1,000 different probes across all major ultrasound companies, and offers an effective traceability solution with AcuTrace, capturing required information to create audit-ready digital disinfection records. The platform also offers the option for hospitals to integrate trophon2 into their IT systems with AcuTrace Plus, thereby centrally storing disinfection records for easy access by the entire IT system and linking information directly to patients’ electronic medical records.

For more information: www.nanosonics.us

References

  1. https://www.healthimaging.com/topics/healthcare-economics-policy/8-globa...
  2. GOV.UK Medical Safety Alert; Reusable transesophageal echocardiography, transvaginal and transrectal ultrasound probes (transducer) – failure to appropriately decontaminate. (https://www.gov.uk/drug-device-alerts/medical-device-alert-reusable-tran...)

Related Content

The Revolution Apex intelligent computed tomography (CT) scanner

The Revolution Apex intelligent computed tomography (CT) scanner. Image courtesy of GE Healthcare.

News | RSNA | October 18, 2019
At the 2019 annual meeting of the Radiological Society of North America (RSNA 2019), Dec. 1-6 in Chicago, GE Healthcare...
Philips Partners With PURE on Tele-Ultrasound Program for Physicians in Rwanda
News | Ultrasound Imaging | October 09, 2019
Philips and non-profit organization PURE (Point-of-care Ultrasound in Resource-limited Environments) highlighted a tele...
Samsung to Unveil Hera I10 Ultrasound at SDMS 2019
Technology | Ultrasound Women's Health | September 28, 2019
NeuroLogica, a subsidiary of Samsung Electronics Co. Ltd., announced that the Samsung Hera I10 ultrasound system has...
Fujifilm Sonosite Partnering With Artificial Intelligence Incubator to Improve Ultrasound Image Interpretation
News | Ultrasound Imaging | September 23, 2019
Fujifilm SonoSite Inc. and the Allen Institute of Artificial Intelligence (AI2) Incubator, builder of AI-first startups...
Medical Imaging Rates Continue to Rise Despite Push to Reduce Their Use
News | Radiology Imaging | September 03, 2019
Despite a broad campaign among physician groups to reduce the amount of medical imaging, use rates of various scans...
Philips Debuts Cardiac Ultrasound and Enterprise Informatics Offerings at ESC 2019
News | Cardiac Imaging | August 30, 2019
Philips will showcase its latest cardiac care innovations at the European Society of Cardiology (ESC) Congress 2019,...
CIRS Launches Ultrasound Quality Assurance Software
Technology | Quality Assurance (QA) | August 30, 2019
August 30, 2019 — The CIRS Ultrasound...
Terason Partners With DiA Imaging Analysis for Point-of-care Cardiac Ultrasound AI
News | Cardiovascular Ultrasound | August 26, 2019
Ultrasound imaging company Terason has partnered with DiA Imaging Analysis, provider of artificial intelligence (AI)-...
Exo Imaging Raises $35 Million for Developmental Ultrasound Platform
News | Ultrasound Imaging | August 23, 2019
Exo Imaging Inc. announced a $35 million Series B financing round for its high-performance ultrasound platform based on...